ILLUMINA INC (ILMN) Stock News

First Week of ILMN September 19th Options Trading

Illumina CEO Thaysen on Nvidia Partnership, Genomics, M&A

Illumina CEO Jacob Thaysen discusses the outlook for genomics and the company's partnership with Nvidia. He speaks with Katherine Greifeld at the JPMorgan Health-Care Conference in San Francisco. (Source: Bloomberg)

Illumina Raises Q4 Revenue Outlook To $1.10 Billion, Exceeding Street Expectations; Sees Solid Margins

Illumina raises Q4 and FY24 revenue outlook, expects solid margins, with projected 2024 EPS between $4.12 and $4.14.

Nvidia Eyes $1 Billion In Healthcare AI Revenue: Is This The Next Growth Frontier?

Nvidia is making an ambitious leap into leveraging AI and accelerated computing to transform healthcare solutions.

Illumina and NVIDIA collaborate to decode biology and propel precision health

/PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN), a global leader in genomic sequencing and analysis, today announced it is collaborating with NVIDIA to advance...

Nvidia Unveils Tie-Ups With Illumina, Mayo Clinic in Health Push

Nvidia Corp. announced tie-ups with Illumina Inc., the Mayo Clinic and other health-care organizations as part of its push to encourage the adoption of artificial intelligence by that industry.

Truveta sells stakes to Regeneron, Illumina in deal to build genetic database

Medical data research company Truveta said on Monday that Regeneron Pharmaceuticals, Illumina and 17 U.S. health systems will take a $320 million stake in the company as part of a deal to build the world's largest genetic database. Biotechnology company Regeneron pledged to put in $120 million and genetic sequencing company Illumina is investing $20 million. The rest will come from U.S. health systems including New York-based Northwell Health, multi-state non-profit Trinity Health and Advocate Health, based in Chicago.

Illumina launches pilot proteomics program with UK Biobank and biopharma collaborators to analyze 50,000 samples

/PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced a pilot proteomics program to...

Illumina to Announce Fourth Quarter and Full Year 2024 Financial Results on Thursday, February 6, 2025

/PRNewswire/ -- Illumina, Inc. (NASDAQ:ILMN) announced today that it will issue results for the fourth quarter and full year 2024 following the close of market...

Illumina advances NovaSeq X Series, delivering single-flow-cell system, software upgrade, and new kits to enable multiomic applications

/PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced a series of updates to its...

February 2025 Options Now Available For Illumina (ILMN)

Super Micro slides 7% after stock is dropped from Nasdaq 100

Super Micro is exiting the Nasdaq 100 after just five months in the index.

What's Going On With Illumina Stock On Monday?

On Friday, Nasdaq Inc’s (NASDAQ:NDAQ) annual reconstitution of the Nasdaq-100 Index will become effective before the market opens on December 23. Illumina, Inc. (NASDAQ:ILMN) was removed from the index. Year to date, the stock has increased around 8%, underperforming iShares Core S&P Mid-Cap ETF (NYSE:IJH). The provider of DNA sequencing and array-based technologies has been in the news due to its controversial multi-billion dollar deal to acquire cancer test maker Grail Inc (NASDAQ:GRAL). Also

Palantir Stock Is Joining the Nasdaq-100 Index, and Super Micro Computer Is Being Booted: What Investors Should Know

Palantir stock's huge rise this year has earned it a spot on another stock index.

GRAIL: Biotech Stock Targeting $100B Cancer Market

GRAIL is a small biotech stock on the rise big time recently. Its innovative technology gives it the opportunity to capitalize on a massive addressable market.

MicroStrategy, Palantir Added to Nasdaq 100, Moderna Removed

MicroStrategy Inc., the dot-com-era software maker whose metamorphosis into a leveraged bet on Bitcoin has transfixed Wall Street, is joining the Nasdaq 100 Index, the benchmark’s overseer said Friday. Software company Palantir Technologies Inc. and Axon Enterprise Inc., a maker of Tasers and police body cameras, will also be added.

Palantir, MicroStrategy, and Axon Enterprise To Join Nasdaq 100

Palantir, MicroStrategy, and Axon Enterprise are set to join the Nasdaq 100 Index on Monday, Dec. 23, replacing Super Micro Computer, Moderna, and Illumina.